Marcie J. Hursting
BioSciCon (United States)(US)
Publications by Year
Research Areas
Heparin-Induced Thrombocytopenia and Thrombosis, Venous Thromboembolism Diagnosis and Management, Intramuscular injections and effects, Platelet Disorders and Treatments, Atrial Fibrillation Management and Outcomes
Most-Cited Works
- → Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia(2001)657 cited
- → The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal Dysfunction(2000)371 cited
- → When Heparins Promote Thrombosis(2005)244 cited
- → Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin‐induced thrombocytopenia(2002)205 cited
- → Novastan®(Brand of Argatroban): A Small-Molecule, Direct Thrombin Inhibitor(1997)152 cited
- → A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease(2004)140 cited
- → Growth Signals, Inflammation, and Vascular Perturbations(2012)129 cited
- → Calorie restriction and cancer prevention: a mechanistic perspective(2013)127 cited
- → Effects of Argatroban Therapy, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia(2006)121 cited
- → Argatroban Anticoagulation in Patients With Acute Ischemic Stroke (ARGIS-1)(2004)114 cited